| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| 8-K | Report | Data | 8-K | Aug 15, 2024 | Jul 26, 2024 |
| 8-K | Report | Data | 8-K | Jul 12, 2024 | May 23, 2024 |
| 8-K | Report | Data | 8-K | May 16, 2024 | Mar 22, 2024 |
| 8-K | Report | Data | 8-K | Mar 12, 2024 | Mar 6, 2024 |
| 8-K | Report | Data | 8-K | Nov 29, 2023 | Nov 17, 2023 |
| 8-K | Report | Data | 8-K | Oct 3, 2023 | Sep 27, 2023 |
| 8-K | Report | Data | 8-K | Sep 27, 2023 | Sep 22, 2023 |
| 8-K | Report | Data | 8-K | Aug 25, 2023 | Jul 24, 2023 |
| 8-K | Report | Data | 8-K | Jun 30, 2023 | Jun 22, 2023 |
| 8-K | Report | Data | 8-K | May 30, 2023 | May 23, 2023 |
| 8-K | Report | Data | 8-K | May 10, 2023 | May 4, 2023 |
| 8-K | Report | Data | 8-K | Mar 24, 2023 | Mar 21, 2023 |
| 8-K | Report | Data | 8-K | Feb 24, 2023 | Feb 21, 2023 |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2023 | |
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 6, 2023 | |
| 8-K | Report | Data | 8-K | Jan 25, 2023 | Jan 19, 2023 |
| 8-K | Report | Data | 8-K | Jan 17, 2023 | Jan 13, 2023 |
| 8-K | Report | Data | 8-K | Dec 23, 2022 | Dec 20, 2022 |
| 8-K | Report | Data | 8-K | Dec 2, 2022 | Nov 28, 2022 |
| 8-K | Report | Data | 8-K | Nov 23, 2022 | Nov 21, 2022 |
| 8-K | Report | Data | 8-K | Nov 8, 2022 | Nov 4, 2022 |
| SC 13D/A | Report | NEW ENTERPRISE ASSOCIATES 13, LP (PHASEBIO PHARMACEUTICALS) - SCHEDULE 13D/A#1E | Nov 4, 2022 | |
| 8-K | Report | Data | 8-K | Oct 31, 2022 | Oct 25, 2022 |
| 8-K | Report | Data | 8-K | Oct 24, 2022 | Oct 23, 2022 |
| 8-K | Report | Data | 8-K | Oct 7, 2022 | Oct 3, 2022 |
| 8-K | Report | Data | 8-K | Sep 27, 2022 | Sep 21, 2022 |
| 10-Q | Report | Data | 10-Q | Aug 12, 2022 | Jun 30, 2022 |
| 8-K | Report | Data | 8-K | Aug 12, 2022 | Aug 12, 2022 |
| 8-K | Report | Data | 8-K | Aug 8, 2022 | Aug 4, 2022 |
| SC 13G/A | Report | Jul 19, 2022 | ||
| 8-K | Report | Data | 8-K | Jul 5, 2022 | Jun 29, 2022 |
| 8-K | Report | Data | 8-K | May 20, 2022 | May 19, 2022 |
| 10-Q | Report | Data | 10-Q | May 16, 2022 | Mar 31, 2022 |
| 8-K | Report | Data | 8-K | May 16, 2022 | May 16, 2022 |
| 8-K | Report | Data | 8-K | Apr 4, 2022 | Apr 4, 2022 |
| 10-K | Report | Data | 10-K | Mar 24, 2022 | Dec 31, 2021 |
| 8-K | Report | Data | 8-K | Mar 24, 2022 | Mar 24, 2022 |
| SC 13G/A | Report | Feb 15, 2022 | ||
| SC 13G/A | Report | SC 13G/A | Feb 14, 2022 | |
| SC 13G/A | Report | PHASEBIO PHARMACEUTICALS INC | Feb 14, 2022 | |
| SC 13G/A | Report | Feb 14, 2022 | ||
| SC 13G | Report | SEC SCHEDULE 13G | Feb 4, 2022 | |
| SC 13G/A | Report | SCHEDULE 13G-A FOR PHASEBIO PHARMACEUTICALS, INC. | Feb 1, 2022 | |
| 8-K | Report | Data | 8-K | Dec 21, 2021 | Dec 21, 2021 |
| 8-K | Report | Data | 8-K | Nov 15, 2021 | Nov 15, 2021 |
| 10-Q | Report | Data | 10-Q | Nov 10, 2021 | Sep 30, 2021 |
| 8-K | Report | Data | 8-K | Nov 10, 2021 | Nov 10, 2021 |
| SC 13G/A | Report | SEC SCHEDULE 13G | Nov 10, 2021 | |
| 8-K | Report | Data | 8-K | Nov 3, 2021 | Nov 3, 2021 |
| 8-K | Report | Data | 8-K | Sep 15, 2021 | Sep 14, 2021 |
| 10-Q | Report | Data | 10-Q | Aug 12, 2021 | Jun 30, 2021 |
| 8-K | Report | 8-K | Aug 12, 2021 | Aug 12, 2021 |
| 8-K | Report | 8-K | Aug 10, 2021 | Aug 10, 2021 |
| SC 13G/A | Report | SEC SCHEDULE 13G | Aug 10, 2021 | |
| 8-K | Report | 8-K | Jun 17, 2021 | Jun 16, 2021 |
| 8-K | Report | 8-K | Jun 4, 2021 | Jun 3, 2021 |
| SC 13G | Report | SC 13G | May 19, 2021 | |
| 10-Q | Report | Data | 10-Q | May 13, 2021 | Mar 31, 2021 |
| 8-K | Report | 8-K | May 13, 2021 | May 13, 2021 |
| SC 13G | Report | SC 13G | Mar 24, 2021 | |
| SC 13G | Report | Mar 22, 2021 | ||
| 8-K | Report | 8-K | Mar 19, 2021 | Mar 17, 2021 |
| 10-K | Report | Data | 10-K | Mar 15, 2021 | Dec 31, 2020 |
| 8-K | Report | 8-K | Mar 15, 2021 | Mar 15, 2021 |
| 8-K | Report | 8-K | Mar 11, 2021 | Mar 10, 2021 |
| SC 13G/A | Report | Feb 16, 2021 | ||
| 8-K | Report | 8-K | Jan 28, 2021 | Jan 28, 2021 |
| 8-K | Report | 8-K | Jan 27, 2021 | Jan 27, 2021 |
| SC 13G/A | Report | SEC SCHEDULE 13G | Jan 11, 2021 | |
| SC 13G | Report | Nov 16, 2020 | ||
| 10-Q | Report | Data | 10-Q | Nov 12, 2020 | Sep 30, 2020 |
| 8-K | Report | 8-K | Nov 12, 2020 | Nov 12, 2020 |
| 8-K | Report | 8-K | Oct 23, 2020 | Oct 23, 2020 |
| 8-K | Report | 8-K | Oct 6, 2020 | Oct 6, 2020 |
| 10-Q | Report | Data | 10-Q | Aug 11, 2020 | Jun 30, 2020 |
| 8-K | Report | 8-K | Aug 11, 2020 | Aug 11, 2020 |
| 8-K | Report | 8-K | Jul 16, 2020 | Jul 16, 2020 |
| 8-K | Report | 8-K | Jun 5, 2020 | Jun 3, 2020 |
| 8-K | Report | 8-K | May 27, 2020 | May 27, 2020 |
| 10-Q | Report | Data | 10-Q | May 12, 2020 | Mar 31, 2020 |
| 8-K | Report | 8-K | May 12, 2020 | May 12, 2020 |
| 10-K | Report | Data | 10-K | Mar 30, 2020 | Dec 31, 2019 |
| 8-K | Report | 8-K | Mar 30, 2020 | Mar 30, 2020 |
| 8-K | Report | 8-K | Mar 20, 2020 | Mar 19, 2020 |
| 8-K | Report | 8-K | Mar 4, 2020 | Mar 4, 2020 |
| SC 13G/A | Report | Feb 14, 2020 | ||
| 8-K | Report | 8-K | Feb 13, 2020 | Feb 12, 2020 |
| 8-K | Report | 8-K | Feb 11, 2020 | Feb 11, 2020 |
| 8-K | Report | 8-K | Feb 4, 2020 | Feb 4, 2020 |
| SC 13G/A | Report | SEC SCHEDULE 13G | Jan 27, 2020 | |
| SC 13G/A | Report | SCHEDULE 13G FOR PHASEBIO PHARMACEUTICALS, INC. BY JOHNSON & JOHNSON, DATED 12.3 | Jan 17, 2020 | |
| 8-K | Report | 8-K | Jan 13, 2020 | Jan 9, 2020 |
| 8-K | Report | 8-K | Jan 10, 2020 | Jan 9, 2020 |
| 10-Q | Report | Data | 10-Q | Nov 14, 2019 | Sep 30, 2019 |
| 8-K | Report | 8-K | Nov 14, 2019 | Nov 14, 2019 |
| 8-K | Report | 8-K | Oct 15, 2019 | Oct 15, 2019 |
| 8-K | Report | 8-K | Sep 24, 2019 | Sep 24, 2019 |
| 8-K | Report | 8-K | Aug 14, 2019 | Aug 14, 2019 |
| 10-Q | Report | Data | 10-Q | Aug 14, 2019 | Jun 30, 2019 |
| 8-K | Report | 8-K | Aug 13, 2019 | Aug 13, 2019 |
| SC 13D/A | Report | SC 13D/A | Jul 29, 2019 | |
| 8-K | Report | 8-K | Jul 1, 2019 | Jul 1, 2019 |
| 8-K | Report | 8-K | Jun 17, 2019 | Jun 17, 2019 |
| 8-K | Report | 8-K | May 13, 2019 | May 9, 2019 |
| 10-Q | Report | Data | 10-Q | May 9, 2019 | Mar 31, 2019 |
| 8-K | Report | 8-K | May 9, 2019 | May 9, 2019 |
| SC 13G | Report | SCHEDULE 13G HOLDINGS REPORT | Apr 22, 2019 | |
| 8-K | Report | 8-K | Apr 10, 2019 | Apr 9, 2019 |
| 8-K | Report | 8-K | Apr 9, 2019 | Apr 9, 2019 |
| 8-K | Report | 8-K | Apr 8, 2019 | Apr 8, 2019 |
| 8-K | Report | 8-K | Apr 4, 2019 | Apr 1, 2019 |
| 10-K | Report | Data | 10-K | Mar 26, 2019 | Dec 31, 2018 |
| 8-K | Report | 8-K | Mar 26, 2019 | Mar 25, 2019 |
| 8-K | Report | 8-K | Mar 21, 2019 | Mar 17, 2019 |
| 8-K | Report | 8-K | Mar 4, 2019 | Feb 27, 2019 |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 12, 2019 | |
| 8-K | Report | 8-K | Jan 25, 2019 | Jan 25, 2019 |
| SC 13G | Report | SCHEDULE 13G FOR PHASEBIO PHARMACEUTICALS, INC. BY JOHNSON & JOHNSON | Jan 22, 2019 | |
| 8-K | Report | 8-K | Dec 17, 2018 | Dec 13, 2018 |
| 10-Q | Report | Data | 10-Q | Nov 29, 2018 | Sep 30, 2018 |
| 8-K | Report | 8-K | Nov 29, 2018 | Nov 27, 2018 |
| SC 13G | Report | SEC SCHEDULE 13G | Nov 13, 2018 | |
| SC 13D/A | Report | SC 13D/A | Nov 8, 2018 | |
| SC 13D | Report | SC 13D | Nov 1, 2018 | |
| SC 13D | Report | NEW ENTERPRISE ASSOC. 13, LP - PHASEBIO PHARMACEUTICALS, INC. -- SCHEDULE 13D | Oct 31, 2018 | |
| SC 13D | Report | SC 13D | Oct 29, 2018 | |
| 8-K | Report | 8-K | Oct 22, 2018 | Oct 22, 2018 |